Tonix Pharmaceuticals (TNXP) Reports Q2 Loss of $0.50/Share
- Amazon, health stocks weigh on S&P, Nasdaq; Chevron lifts Dow
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- AbbVie (ABBV) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.50), versus ($0.73) reported last year.
For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Remains Bullish on Amazon.com (AMZN) Following 3Q
- First Capital (FCAP) Reports Q3 EPS of $0.53
- CTS Corp. (CTS) Tops Q3 EPS by 4c; Guides FY16
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!